Biostax Corp (BTAX)

[Ahjon81]

CBLI filed S4/A On April 26, 2021, Cytocom entered into a Loan and Security Agreement (“LSA”) for a $15 million loan with Avenue Venture Opportunities Fund, L.P. (“Avenue”). Under the terms of the LSA, Cytocom borrowed $15 million at closing.
Combined companies have roughly 30M in cash

Over the next 12 months, Cytocom believes it will require between $25 million and $40 million to meet its ongoing and projected expenses and obligations.